|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| C07K 14/54 | (2006.01) | ||
| C07K 14/715 | (2006.01) |
| (11) | Number of the document | 3281521 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17193855.8 |
| Date of filing the European patent application | 2015-05-07 | |
| (97) | Date of publication of the European application | 2018-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation | 2021-09-27 |
| (30) | Number | Date | Country code |
| 201461989757 P | 2014-05-07 | US |
| (72) |
WANG, Li-Hsien , US
XUE, Yingzi , US
MURPHY, Andrew J. , US
STEVENS, Sean , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Humanizuotus IL-4 ir IL-4R alfa apimantis gyvūnai |
| HUMANIZED IL-4 AND IL-4R ALPHA ANIMALS |
| Payment date | Validity (years) | Amount | |
| 2024-04-18 | 10 | 231.00 EUR |
| 2025-05-07 |